Via Mid Year News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Das Biotech-Unternehmen steigert seine Einnahmen klar und baut seinen Verlust nahezu vollständig ab.

Research programs goesBusiness developmentCost for researchHalf yearMilestone paymentsSociety wednesdayMedia releasePrior year periodIndication spinePrevious yearSales increaseVia mid yearFull yearWith viewHalf of the yearUros biosciences n